Goldman Sachs’s Jasper Therapeutics JSPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
249,793
+16,035
| +7% | +$89K | ﹤0.01% | 3646 |
|
|
2025
Q1 | $1.01M | Buy |
233,758
+23,453
| +11% | +$101K | ﹤0.01% | 3806 |
|
|
2024
Q4 | $4.5M | Buy |
210,305
+154,540
| +277% | +$3.3M | ﹤0.01% | 2934 |
|
|
2024
Q3 | $1.05M | Buy |
55,765
+19,564
| +54% | +$368K | ﹤0.01% | 3729 |
|
|
2024
Q2 | $822K | Buy |
+36,201
| New | +$822K | ﹤0.01% | 3682 |
|
|
2023
Q2 | – | Sell |
-31,041
| Closed | -$56.2K | – | 5047 |
|
|
2023
Q1 | $56.2K | Buy |
+31,041
| New | +$56.2K | ﹤0.01% | 4749 |
|
|
2022
Q3 | – | Sell |
-10,269
| Closed | -$20K | – | 5579 |
|
|
2022
Q2 | $20K | Sell |
10,269
-182
| -2% | -$354 | ﹤0.01% | 5420 |
|
|
2022
Q1 | $37K | Sell |
10,451
-7,298
| -41% | -$25.8K | ﹤0.01% | 5517 |
|
|
2021
Q4 | $139K | Buy |
+17,749
| New | +$139K | ﹤0.01% | 5116 |
|
|
2021
Q3 | – | Sell |
-283,965
| Closed | -$2.82M | – | 5440 |
|
|
2021
Q2 | $2.82M | Hold |
283,965
| – | – | ﹤0.01% | 3233 |
|
|
2021
Q1 | $2.81M | Sell |
283,965
-64,035
| -18% | -$634K | ﹤0.01% | 3091 |
|
|
2020
Q4 | $3.48M | Sell |
348,000
-171,255
| -33% | -$1.71M | ﹤0.01% | 2703 |
|
|
2020
Q3 | $5.15M | Buy |
+519,255
| New | +$5.15M | ﹤0.01% | 2358 |
|